UroMems

About UroMems

UroMems is a global company focused on developing breakthrough, automated technology to treat stress urinary incontinence (SUI). Their mission is to improve the quality of life for women and men through innovative, smart active implantable medical devices that are easy to use and tailored to individual needs.

Products & Services

UroActive:A smart active implantable medical device designed to treat stress urinary incontinence in men and women. It remotely adjusts to individual needs, offering a simple and efficient solution for an improved quality of life. Currently under development and not yet available for prescription or use.

Specialties

Smart active implantable medical devices Stress urinary incontinence treatment Embedded systems Micro-technologies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 47000000 MR: - FA: $47 million €44 Million FAN: 47000000	D: 2024-06-25 FD: 2024-06-25	8 investors

Series C Latest

2024-06-25

$47.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Emmanuel CHARTIER-KASTLER

Professor and Chief, Division of Urology, Academic Hospital Pitié-Salpétrière (AP-HP), Medical School Sorbonne Université, Paris, France

J

Jan-Paul ROOVERS

Professor of Gynaecology, University of Amsterdam's Faculty of Medicine

T

Ty ERICKSON

Urogynocologist

D

Daniel ELLIOTT

Urologist

D

Dan Rose

Chairman

H

Hamid Lamraoui

Biomedical Engineer

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

UroMems Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised